Barry A. Coomber - Concepedia

Author

Barry A. Coomber

GlaxoSmithKline (United Kingdom)

Also Known As

B COOMBER, B Coomber, B.A. Coomber, Barry A Coomber, Barry A. COOMBER, Barry A. Coomber, Barry Coomber

Publications

219

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)

About

Barry A. Coomber is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	121
2	Natural Sciences	4	4	74
3	Biochemistry	4	4	74
4	Engineering	3	3	70
5	Biomolecular Engineering	2	2	29

Barry A. Coomber

Publications

215

Citations

H-Index

Page 1

	Year	Citations
Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides Paul G. Wyatt, Barry A. Coomber, Derek N. Evans, Bioorganic & Medicinal Chemistry Letters Further Sar StudiesMedicinal ChemistrySialidase InhibitorsMedicineAntiviral Drug Development	2001	44
A stirred flow calorimeter the excess enthalpies of acetone + water and of acetone + some normal alcohols Barry A. Coomber, C.J. Wormald The Journal of Chemical Thermodynamics Excess EnthalpiesEngineeringMolecular ThermodynamicsDifferential Scanning CalorimetryStirred Flow Calorimeter	1976	41
Expression of atrial natriuretic factor as a cleavable fusion protein with chloramphenicol acetyltransferase in <i>Escherichia coli</i> Colin W. Dykes, A. Brett BOOKLESS, Barry A. Coomber, European Journal of Biochemistry	1988	40
Pyrrolidine-5,5-<i>trans</i>-lactams. 1. Synthesis and Incorporation into Inhibitors of Hepatitis C Virus NS3/4A Protease David Andrews, Seb J. Carey, Helene Chaignot, Organic Letters Medicinal ChemistryBioorganic ChemistryCompound 12BBiochemistryLactam Nitrogen	2002	26
The design of potent, non-peptidic inhibitors of hepatitis C protease David Andrews, Helene Chaignot, Barry A. Coomber, European Journal of Medicinal Chemistry Hepatitis C ProteaseBiochemistryViral HepatitisMedicineNatural Sciences	2003	18
Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease Martin J. Slater, David Andrews, Graham R. Baker, Bioorganic & Medicinal Chemistry Letters Ethyl Pyrrolidine-5,5-trans-lactamsBiochemistryMedicineNatural SciencesAntiviral Drug Development	2002	17
Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies Roberto Solari, D Quint, H Obray, Biochemical Journal EngineeringImmunologyImmune RegulationBiological ActivitiesCd4 T Cell Responses	1989	16
Pyrrolidine-5,5-<i>trans</i>-lactams. 2. The Use of X-ray Crystal Structure Data in the Optimization of P3 and P4 Substituents David Andrews, Helene Chaignot, Barry A. Coomber, Organic Letters X-ray CrystallographyCrystal StructureCombinatorial ChemistryPyrrolidine-5,5-trans-lactam TemplateEngineering	2002	13

Page 1